GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

The actress shares her weight loss journey, revealing she hopes to shed 40 pounds with Ozempic after struggling with body ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

WEIGHT loss jabs could be rolled out by the NHS in pharmacies under plans to make them more widely available and “tackle the ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...

The popular diabetes drug Ozempic may cause temporary hair loss through rapid weight loss and nutritional changes. Medical ...